These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 17167690)

  • 1. NOFSA statement on generic bisphosphonates.
    de Jongh JN
    S Afr Med J; 2006 Nov; 96(11):1138. PubMed ID: 17167690
    [No Abstract]   [Full Text] [Related]  

  • 2. NOFSA statement on generic bisphosphonates.
    Hough S
    S Afr Med J; 2006 Dec; 96(12):1214. PubMed ID: 17252142
    [No Abstract]   [Full Text] [Related]  

  • 3. NOFSA statement on generic bisphosphonates.
    Hough S
    S Afr Med J; 2006 Sep; 96(9):758-60. PubMed ID: 17068638
    [No Abstract]   [Full Text] [Related]  

  • 4. Generic alendronate in the treatment of osteoporosis.
    Kanfer I
    S Afr Med J; 2006 Oct; 96(10):1008-10. PubMed ID: 17164925
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of generic alendronate in the treatment of osteoporosis.
    National Osteoporosis Foundation of South Africa
    S Afr Med J; 2006 Aug; 96(8):696-7. PubMed ID: 17019490
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioequivalence studies on bisphosphonates: the example of alendronate.
    Lainesse A; Ozalp Y; Wong H; Alpan RS
    Arzneimittelforschung; 2004 Sep; 54(9A):569-72. PubMed ID: 15497661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inflammation of the jaws during treatment with bisphosphonates].
    Bartl R
    Dtsch Med Wochenschr; 2011 Oct; 136(41):2109-10. PubMed ID: 21971888
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost effectiveness of denosumab versus oral bisphosphonates for postmenopausal osteoporosis in the US.
    Parthan A; Kruse M; Yurgin N; Huang J; Viswanathan HN; Taylor D
    Appl Health Econ Health Policy; 2013 Oct; 11(5):485-97. PubMed ID: 23868102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Postmenopausal osteoporosis. Bisphosphonates are not all equal].
    MMW Fortschr Med; 2009 Mar; 151(11):46-7. PubMed ID: 19469206
    [No Abstract]   [Full Text] [Related]  

  • 10. Bisphosphonates in the treatment of osteoporosis. Principles and efficacy.
    Papapoulos SE
    Ann Med Interne (Paris); 2000 Oct; 151(6):504-10. PubMed ID: 11104931
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bisphosphonates in osteoporosis; a reevaluation].
    Papapoulos SE; Lockefeer JH
    Ned Tijdschr Geneeskd; 1996 Nov; 140(48):2394-8. PubMed ID: 8984410
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study.
    Bianchi ML; Cimaz R; Bardare M; Zulian F; Lepore L; Boncompagni A; Galbiati E; Corona F; Luisetto G; Giuntini D; Picco P; Brandi ML; Falcini F
    Arthritis Rheum; 2000 Sep; 43(9):1960-6. PubMed ID: 11014345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Osteoporosis medications. Bisphosphonates exceed the others].
    MMW Fortschr Med; 2003 Oct; 145(42):66. PubMed ID: 14655453
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group.
    Schnitzer T; Bone HG; Crepaldi G; Adami S; McClung M; Kiel D; Felsenberg D; Recker RR; Tonino RP; Roux C; Pinchera A; Foldes AJ; Greenspan SL; Levine MA; Emkey R; Santora AC; Kaur A; Thompson DE; Yates J; Orloff JJ
    Aging (Milano); 2000 Feb; 12(1):1-12. PubMed ID: 10746426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Are there differences in bisphosphonates? (interview by Dr. Beate Schumacher)].
    Adachi JD
    MMW Fortschr Med; 2004 Aug; 146(31-32):53. PubMed ID: 15529719
    [No Abstract]   [Full Text] [Related]  

  • 16. [Alendronate--a new drug for treatment of osteoporosis].
    Pluskiewicz W; Drozdzowska B
    Chir Narzadow Ruchu Ortop Pol; 1997; 62(1):73-7. PubMed ID: 9198552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Osteoporosis therapy. Bisphosphonates compared].
    MMW Fortschr Med; 2003 Mar; 145(13):60. PubMed ID: 15101545
    [No Abstract]   [Full Text] [Related]  

  • 18. Bisphosphonates in the treatment of osteoporosis.
    Hochberg MC
    Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):53S-55S. PubMed ID: 9273939
    [No Abstract]   [Full Text] [Related]  

  • 19. By the way, doctor. My doctor prescribed Fosamax to me for osteoporosis prevention, but it upsets my stomach. Are there any other proven medications for osteoporosis prevention?
    Robb-Nicholson C
    Harv Womens Health Watch; 2000 Aug; 7(12):8. PubMed ID: 10927664
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bisphosphonates: pharmacology and use in the treatment of osteoporosis].
    Kishimoto H
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():350-8. PubMed ID: 11979929
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.